Sort
130,381 grants matching “hiv”
NETWORKS, NORMS AND HIV/STI RISK AMONG YOUTH
$818,269National Development &Res Institutes · R01 · FY2001 · DA
The Neural Underpinnings of Depression and Cannabis Use in Young PLWH
$818,232Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2021 · DA
The Neural Underpinnings of Depression and Cannabis Use in Young PLWH
$818,231Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2022 · DA
Genomic Sequencing to Establish a Macaque Genotype and Phenotype Research Resource
$818,146Betsy M Ferguson · Oregon Health & Science University · R24 · FY2019 · OD
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
$818,107Paul Kievit · Oregon Health & Science University · R01 · FY2024 · AG
Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention
$817,933John Schneider · University Of Chicago · R01 · FY2018 · AI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons
$817,851Jacqueline Michele Achkar · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Incentives for Suppression of HIV-1 RNA in People Living with HIV
$817,836Kenneth Silverman · Johns Hopkins University · R01 · FY2015 · AI
Influence of neighborhoods and networks on the HIV care continuum among HIV-infected MSM in NYC
$817,785Hong Van Nhu Tieu · New York Blood Center · R56 · FY2017 · MH
Intensive Models of HCV Care for Injection Drug Users
$817,702Alain Litwin · Albert Einstein College Of Medicine · R01 · FY2012 · DA
Kaposi's sarcoma and human herpesvirus in Africa
$817,681Charles Wood · University Of Nebraska Lincoln · R01 · FY2007 · CA
DRUG USERS IN NEW YORK AND PUERTO RICO--HIV RISK BEHAVIO
$817,679National Development &Res Institutes · R01 · FY2000 · DA
Host Genetic Determinants of HIV Pathogenesis
$817,656Sunil K Ahuja · University Of Texas Hlth Science Center · R37 · FY2008 · AI
St. Jude-Memphis Adolescent Trials Unit
$817,570Aditya H Gaur · St. Jude Children'S Research Hospital · U01 · FY2015 · HD
Improving the Organizational Social Context to Address Structural Racism and Discrimination: A Randomized Controlled Trial to Reduce Racial Disparities in Viral Suppression and Retention in HIV Care
$817,490Florence M Momplaisir · University Of Pennsylvania · R01 · FY2022 · NR
NETWORKS, NORMS AND HIV/STI RISK AMONG YOUTH
$817,484National Development &Res Institutes · R01 · FY2002 · DA
Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery
$817,309Alejandro Benjamin Balazs · Massachusetts General Hospital · R01 · FY2025 · AI
Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection
$817,262Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2022 · AG
Investigating Multiple PK and PD Relationships for TB-HIV (IMPPRove TB-HIV)
$817,252Kelly E. Dooley · Vanderbilt University Medical Center · R56 · FY2023 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis
$817,242Leah Elizabeth Cowen · University Of Toronto · R01 · FY2017 · AI
A preclinical assessment of monthly intramuscular GSK1265744, an InSTI, as PrEP
$817,211Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2015 · AI
HIV-1 vaccine-elicited antibodies target envelope glycans
$817,205Kevin O Saunders · Duke University · R01 · FY2020 · AI
Long-acting multi prevention implant for 2-year contraception and HIV PrEP
$817,162Alessandro Grattoni · Methodist Hospital Research Institute · R01 · FY2025 · AI
Characterizing Sleep, ART Adherence and Viral Suppression Among Black Sexual Minority Men
$817,152Dustin T Duncan · Columbia University Health Sciences · R01 · FY2021 · HL
Macrophages in the pathogenesis of AIDS
$817,150Marcelo J Kuroda · Tulane University Of Louisiana · R01 · FY2014 · AI